Jefferies Upgrades Teva Pharma (TEVA) to Buy, 'Expect Trends to Drive Better Guide + Biosim Call Options'
Tweet Send to a Friend
(Updated - January 23, 2024 4:24 AM EST)
Jefferies analyst Glen Santangelo upgraded Teva Pharma (NYSE: TEVA) from Hold ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Glen Santangelo upgraded Teva Pharma (NYSE: TEVA) from Hold ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
